tiprankstipranks
Revolution Medicines, Inc. (RVMD)
NASDAQ:RVMD
US Market
RVMD
Revolution Medicines
RESEARCH TOOLSreports
Want to see RVMD full AI Analyst Report?

Revolution Medicines (RVMD) Stock News & Sentiment

769 Followers
Revolution Medicines Advances Daraxonrasib Into Phase 3 Pancreatic Cancer Trial, Raising Long-Term Upside Potential
Premium
Company Announcements
Revolution Medicines Advances Daraxonrasib Into Phase 3 Pancreatic Cancer Trial, Raising Long-Term Upside Potential
12d ago
RVMD
Revolution Medicines Warrants: Balancing Dilution Risk and Potential Worthlessness Ahead of 2026 Expiry
Premium
Company Announcements
Revolution Medicines Warrants: Balancing Dilution Risk and Potential Worthlessness Ahead of 2026 Expiry
18d ago
RVMD
Revolution Medicines Signals Breakout With RAS Wins
Premium
Company Announcements
Revolution Medicines Signals Breakout With RAS Wins
18d ago
RVMD
Revolution Medicines: Buy Rating Backed by Strong Daraxon Launch Signals and Pancreatic Cancer Upside Optionality
Premium
Ratings
Revolution Medicines: Buy Rating Backed by Strong Daraxon Launch Signals and Pancreatic Cancer Upside Optionality
19d ago
RVMD
Ami Fadia Reiterates Buy on Revolution Medicines, Slightly Lowers Price Target to $183 Amid Higher Non‑Cash Expenses and Expanded RASolute 301 Trial
Premium
Ratings
Ami Fadia Reiterates Buy on Revolution Medicines, Slightly Lowers Price Target to $183 Amid Higher Non‑Cash Expenses and Expanded RASolute 301 Trial
19d ago
RVMD
Revolution Medicines: Buy Rating Reiterated as Pipeline Advances, Trial Upsized, and $263 Price Target Maintained
Premium
Ratings
Revolution Medicines: Buy Rating Reiterated as Pipeline Advances, Trial Upsized, and $263 Price Target Maintained
19d ago
RVMD
Revolution Medicines: Daraxonrasib Data De‑Risk Pivotal Pancreatic Cancer Program, Supporting Buy Rating and $169 Target
Premium
Ratings
Revolution Medicines: Daraxonrasib Data De‑Risk Pivotal Pancreatic Cancer Program, Supporting Buy Rating and $169 Target
1M ago
RVMD
More RVMD News >

RVMD News on the Web

Bernstein starts Revolution Medicines at Market Perform, says upside baked in
TipRanks News
Neutral
Revolution Medicines initiated with a Market Perform at Bernstein
TipRanks News
Neutral
Revolution Medicines assumed with a Buy at Truist
TipRanks News
Bullish
Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares | The Motley Fool
Motley Fool
Neutral
This Trade School Stock Is Up 135%. Here’s Why a Fund Still Bought 459,000 Shares | The Motley Fool
Motley Fool
Neutral
Callaway Stock Has Soared 150%. Here’s Why One Fund Still Bought 1.1 Million Shares | The Motley Fool
Motley Fool
Neutral
Revolution Medicines Advances Daraxonrasib Into Phase 3 Pancreatic Cancer Trial, Raising Long-Term Upside Potential
TipRanks News
Bullish
Adlai Nortye initiated with a Buy at JonesResearch
TipRanks News
Bearish

News Score - Last 7 Days

Not enough data to generate a sentiment score
RVMD
Sector Average
Media Buzz
This Week2 articles
Weekly Average11.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RVMD’s Media Buzz Sentiment?
2 articles about RVMD were published this week. In an average week, 11.5 articles are published.
    What is RVMD’s weekly average amount of articles?
    In an average week, 11.5 articles about RVMD are published.
      What is RVMD’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      IMVTImmunovant
      ROIVRoivant Sciences
      ADOAnteoTech Ltd
      JUNSJupiter Neurosciences, Inc.
      AFPAFT Pharmaceuticals Ltd.
      Showing the stocks with the most bullish news sentiment over the past week